We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada: New Premarket Requirements Aimed at Reducing Medication Errors
Canada: New Premarket Requirements Aimed at Reducing Medication Errors
Starting next year, drug companies seeking to market products in Canada will need to provide the regulatory authority with information on proposed names, labels and packages.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor